Home

Vivo Opportunity Fund Holdings, L.P.

CIK 1930214 · last filed 2024-05-01

Vivo Opportunity Fund Holdings, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for UNCY, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$103.4M, making them a net seller over the disclosed history. The firm reports its address in Palo Alto, CA. 18 SEC filings were submitted jointly with Vivo Opportunity, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

6

Lifetime Open-Market Net

-$103.40M

Filer Profile

Reported Address
192 LYTTON AVENUE
PALO ALTO, CA 94301
Phone
(650) 688-0818
State of Incorporation
DE
Related Filers
Vivo Opportunity, LLC — 18 joint filings, latest 2026-07-16
Vivo Capital Fund VIII, L.P. — 6 joint filings, latest 2024-04-03
Vivo Capital Surplus Fund VIII, L.P. — 6 joint filings, latest 2024-04-03
Vivo Capital VIII, LLC — 6 joint filings, latest 2024-04-03
Vivo Opportunity Cayman Fund, L.P. — 4 joint filings, latest 2026-07-16
Vivo Opportunity Cayman, LLC — 4 joint filings, latest 2026-07-16
Vivo Capital Fund IX, L.P. — 2 joint filings, latest 2023-08-10
Vivo Capital IX, LLC — 2 joint filings, latest 2023-08-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 7,668,093 $53.01 $406.49M -$103.40M 3 2024-05-01

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 UNCY Notice (144) −1,789,916 -$9.45M EDGAR
2024-05-01 SOLENO THERAPEUTICS INC (SLNO) Delisted Sell (S) −2,202,484 -$103.40M EDGAR
2024-04-03 TERN Notice (144) −136,258 -$817.5K EDGAR
2024-04-01 TERN Notice (144) −221,095 -$1.57M EDGAR
2023-10-04 SOLENO THERAPEUTICS INC (SLNO) Delisted Exer (X) +10,430,000 $26.07M EDGAR
2023-09-28 SOLENO THERAPEUTICS INC (SLNO) Delisted Exer (X) +6,406,186 $11.21M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.